AU

Aberdeen U.S. Mid Cap Equity Fund

Mutual Fund
Aberdeen Funds
Last update 2021-09-01 43 Stocks (9 new)
Value $2.00 Mil Turnover 20 %
Countries:
Aberdeen U.S. Mid Cap Equity F... Top Holdings of 2021-01-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
TTEK
Tetra Tech Inc
3,465
84.3
-8.82%
3.520
-0.31%
0.000
+21.99%
-11.22%
9,280.6
Construction
HZNP
Horizon Therapeutics PLC
1,128
81.8
+23.01%
3.420
+0.64%
0.000
+13.24%
+2.20%
26,632.1
Drug Manufacturers
TSX:X
TMX Group Ltd
4,160
80.3
+16.20%
3.360
+0.47%
0.000
+9.70%
+27.05%
15,523.6
Capital Markets
BURL
Burlington Stores Inc
321
79.9
0%
3.340
0%
0.000
+2.52%
-14.78%
15,325.0
Retail - Cyclical
SIVBQ
SVB Financial Group
181
79.2
-21.65%
3.310
-0.67%
0.000
-66.67%
-81.87%
0.4
Banks
NICE
NICE Ltd
302
78.9
0%
3.300
0%
0.000
+18.66%
+3.58%
10,261.1
Software
EPAM
EPAM Systems Inc
222
76.5
0%
3.200
0%
0.000
-12.78%
-25.34%
9,889.9
Software
GMED
Globus Medical Inc
1,236
76.3
0%
3.190
0%
0.000
-24.45%
-28.00%
8,061.8
Medical Devices & Instruments
TFX
Teleflex Inc
194
73.3
+8.99%
3.060
+0.25%
0.000
-8.26%
-30.84%
5,411.4
Medical Devices & Instruments
PEGA
Pegasystems Inc
537
68.4
0%
2.860
0%
0.000
+28.43%
+9.35%
8,715.7
Software

Aberdeen U.S. Mid Cap Equity Fund's Historical Top Holdings Breakdowns

Aberdeen U.S. Mid Cap Equity Fund Total Holding History ($B)

To

Aberdeen U.S. Mid Cap Equity Fund's Asset Allocation

To

Aberdeen U.S. Mid Cap Equity Fund Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Aberdeen U.S. Mid Cap Equity Fund's Hypothetical Growth since 2021-01-31

Aberdeen U.S. Mid Cap Equity Fund's Yearly Returns

Year Portfolio % % Excess Gain %

Aberdeen U.S. Mid Cap Equity Fund's Holdings Heat Map

Size field:

Aberdeen U.S. Mid Cap Equity Fund's Holdings Bubble Chart

Aberdeen U.S. Mid Cap Equity Fund News

  • 1

Discussions on Aberdeen U.S. Mid Cap Equity Fund

No discussions yet.